AEGiS-IRIN: TANZANIA: Study shows problems with relevance and freshness of donated drugs

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

TANZANIA: Study shows problems with relevance and freshness of donated drugs

Integrated Regional Information Networks - August 17, 1999

NAIROBI, 17 August (IRIN) - A WHO study, the results of which were published on Monday, has shown that a substantial proportion of drugs donated to Tanzania and other developing countries by the United States fail to meet local medical needs or have a short shelf life. A study by the Harvard School of Public Health in the US collected data on 16,566 pharmaceuticals shipped to Armenia, Haiti and Tanzania by two relief agencies between 1994 and 1997. About 30 percent of the drugs had a shelf-life of a year or less and six percent had less than 100 days, the study concluded.

Between 10 and 42 percent of the donated drugs were not listed as essential by the recipient country or the WHO Model List of Essential Drugs, nor were they permissible therapeutic alternatives. According to the WHO bulletin, donated drugs also arrived unsorted and inappropriately labelled, and their quality did not always comply with standards in donor countries. On occasion, the drugs also had a high declared value, based on their market value in the donor country, leading to high customs charges for recipients, the report added.
990817
IR990801

Copyright © 1999 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980 – 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .